US-based biotechnology company CTD Holdings has completed issuing 20,000 units of series B convertible preferred stock for the development of its...
Read More...
The post Deals this week: CTD Holdings, Peptron, Hemispherx Biopharma appeared first on Pharmaceutical Technology.
Original Article: Deals this week: CTD Holdings, Peptron, Hemispherx Biopharma